Your session is about to expire
← Back to Search
Blood Test for Lung Cancer (PROACT-LUNG Trial)
Verified Trial
N/A
Recruiting
Research Sponsored by Freenome Holdings Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Are you 50 years or older?
You have been diagnosed with Lung Cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights
Summary
This trial is testing a blood test to see if it can detect lung cancer early in high-risk individuals. Blood samples will be collected from participants who are getting a routine CT scan for lung cancer screening.
Who is the study for?
This trial is for people aged 50 or older who are current or former smokers with a history of smoking at least 20 packs a year. Participants must understand and agree to sign consent forms.
What is being tested?
The study is testing the effectiveness of a new blood test designed to detect lung cancer early in high-risk individuals, alongside their routine low-dose CT scans used for screening.
What are the potential side effects?
Since this trial involves only a blood test and standard care screenings, there are no direct side effects from interventions being studied.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Sensitivity and specificity in detecting lung cancer
Find a Location
Who is running the clinical trial?
Freenome Holdings Inc.Lead Sponsor
4 Previous Clinical Trials
66,675 Total Patients Enrolled
Nasibeh Vatankhah, MDStudy DirectorFreenome Holdings Inc.
Chuanbo Xu, PhDStudy DirectorFreenome Holdings Inc.
Share this study with friends
Copy Link
Messenger